Cellectricon Launches Cellaxess® ACE - Adherent Cell Electroporation System

31 Oct 2012
Share
Cellectricon is pleased to announce the new Cellaxess ACE Adherent Cell Electroporation System which represents a revolutionary in-situ transfection of any adherent cell type. Developed to meet the growing need for in-situ transfection of hard-to-transfect adherent cell types, the platform enables transfection and delivery of non-genetic material in any adherent cell type at any developmental stage.

The platform enables in-situ primary and iPSC-derived cell types directly in 96- and 384-well microplates and cell culture dishes at any cellular developmental stage with excellent viability and completely retained cellular morphology.

Cellaxess ACE is available as a complete system, but can also be integrated with third party pulse generators.

“We are thrilled with the Cellaxess system; it has allowed us to routinely transfect many different types of cultured primary neurons in their adherent state, something that has not previously been possible.”

Professor Peter Baas, Department of Neurobiology and Anatomy, Drexel University, Philadelphia, USA

Applications for the Cellaxess ACE include transfection of various types of neuronal cells such as hippocampal and cortical neurons, dorsal root and superior cervical ganglia from rat as well as mouse, and human iPSC-derived dopaminergic neurons, to mention a few. Protocols are available for a wide range of neuronal cells as well as other adherent cell types.

Request Info


Company website

Cellectricon